Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pacira BioSciences Q2 Adj. EPS $0.74 Beats $0.68 Estimate, Sales $181.099M Miss $183.330M Estimate

Author: Benzinga Newsdesk | August 05, 2025 03:01pm
Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.68 by 9.63 percent. This is a 16.85 percent decrease over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $181.099 million which missed the analyst consensus estimate of $183.330 million by 1.22 percent. This is a 1.73 percent increase over sales of $178.023 million the same period last year.

Posted In: PCRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist